The store will not work correctly when cookies are disabled.
5-hydroxy-1,7-di(1H-pyrrol-2-yl)hepta-1,4,6-trien-3-one
ID: ALA4521765
PubChem CID: 155542650
Max Phase: Preclinical
Molecular Formula: C15H14N2O2
Molecular Weight: 254.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(/C=C(O)/C=C/c1ccc[nH]1)/C=C/c1ccc[nH]1
Standard InChI: InChI=1S/C15H14N2O2/c18-14(7-5-12-3-1-9-16-12)11-15(19)8-6-13-4-2-10-17-13/h1-11,16-18H/b7-5+,8-6+,14-11-
Standard InChI Key: ZNNBVJGJGPEHHG-XTYDYNBASA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
29.9191 -22.2421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6252 -21.8309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3345 -22.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0407 -21.8255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7499 -22.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0376 -21.0083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4561 -21.8202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1653 -22.2261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4530 -21.0030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.8715 -21.8149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5807 -22.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1719 -21.9134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.6274 -22.5228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0387 -23.2290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8373 -23.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6730 -23.0283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4730 -23.1952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8789 -22.4859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3298 -21.8808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
4 6 2 0
5 7 2 0
7 8 1 0
7 9 1 0
8 10 2 0
10 11 1 0
1 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 1 2 0
11 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 11 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 254.29 | Molecular Weight (Monoisotopic): 254.1055 | AlogP: 3.08 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.88 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.76 | CX Basic pKa: ┄ | CX LogP: 2.68 | CX LogD: 2.68 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.44 | Np Likeness Score: 0.86 |
References
1. Rodrigues FC, Anil Kumar NV, Thakur G.. (2019) Developments in the anticancer activity of structurally modified curcumin: An up-to-date review., 177 [PMID:31129455] [10.1016/j.ejmech.2019.04.058] |